Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07219485 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Pitolisant in Participants With Prader-Willi Syndrome

StatusEnrolling by Invitation
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
The purpose of this study is to assess safety of pitolisant in eligible participants with Prader-Willi syndrome (PWS) who completed the End of Treatment (EOT) visit in a parent study (HBS-101-CL-002 \[Open Label Extension (OLE)\], HBS- 101-CL-004, or HBS-101-CL-312 OLE).
Trial Details
NCT Number NCT07219485
Lead Sponsor Harmony Biosciences Management, Inc.
Conditions
(from sponsor)		 Prader-Willi Syndrome
Related terms Prader-Willi Syndrome
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov